Pluto Biosciences, Inc

GSE111073: Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups

Bulk RNA sequencing

Consumption of walnuts has slowed breast cancer growth and/or reduced the risk of breast cancer in mice. The significantly reduced mean tumor size or numbers of tumors was associated with changing the expressions of many genes that are associated with cancer growth, survival and metastasis. Many women treated for breast cancer are interested in reducing the risk for recurrence. The study was a non-placebo, two-arm, clinical trial. Women with lumps large enough for research and pathology biopsies were recruited to the trial. One or two additional biopsies were taken for gene expression analyses using next generation RNA Sequencing methods. The subjects randomized to the walnut group immediately began to consume 2 ounces of walnuts per day until follow-up surgery, if surgery were needed. At follow up surgery, additional biopsies were taken from the surgically removed, cancerous tissue for additional gene expression analyses. Changes in gene expression compared to baseline were determined in tumors of each individual woman in walnut-consuming and control groups. SOURCE: James Denvir (denvir@marshall.edu) - Genomics and Bioinformatics Core Facility Marshall University School of Medicine

View this experiment on Pluto Biosciences, Inc